{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-011160","form_type":"8-K","ticker":"QCLS","cik":"0001321834","company_name":"Q/C TECHNOLOGIES, INC.","filed_at":"2025-03-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.289472+00:00","generated_at":"2026-05-24T08:35:51.165600+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"TNF Pharma receives Nasdaq bid price deficiency notice; 180 days to cure","bullets":["Received Nasdaq letter on March 17, 2025 for failure to maintain minimum $1.00 bid price over 30 consecutive business days.","Compliance period of 180 calendar days until September 15, 2025; must have $1.00 closing bid for 10 consecutive days.","If not cured, may get additional 180 days by meeting other listing standards and providing intent to cure, e.g., reverse stock split."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-011160","json":"https://secwatch.observer/filing/0001493152-25-011160.json","markdown":"https://secwatch.observer/filing/0001493152-25-011160.md","text":"https://secwatch.observer/filing/0001493152-25-011160.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1321834/000149315225011160/0001493152-25-011160-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1321834/000149315225011160/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T08:35:51.165600+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}